Page 95 - 2019秋季手冊內頁-ebook測試

4. Chyuan IT, Hsu PN. Tumor necrosis factor: The key to hepatitis B viral clearance. Cell Mol Immunol. 2018 Aug;15(8):731-733.
5. Chyuan IT, Tsai HF, Liao HJ, Wu CS, Hsu PN. An apoptosis-independent role of TRAIL in suppressing joint inflammation and inhibiting T cell activation in inflammatory arthritis. Cell Mol Immunol. 2018 Sep;15(9):846-857.
6. Tsai HF, Hsu PN. Cancer immunotherapy by targeting immune checkpoints: mechanism of T cell dysfunction in cancer immunity and new therapeutic targets. J Biomed Sci. 2017 May 25;24(1):35.
7. Kuo SH, Wu MS, Yeh KH, Lin CW, Hsu PN, Chen LT, Cheng AL.Novel Insights of Lymphomagenesis of Helicobacter pylori-Dependent Gastric Mucosa-Associated Lymphoid Tissue Lymphoma. Cancers (Basel). 2019 Apr 17;11(4).
8. Ou DL, Lin YY, Hsu CL, Lin YY, Chen CW, Yu JS, Miaw SC, Hsu PN, Cheng AL, Hsu C. Development of a PD-L1-Expressing Orthotopic Liver Cancer Model: Implications for Immunotherapy for Hepatocellular Carcinoma. Liver Cancer. 2019 May;8(3):155-171
9. Tsai HF, Wu CS, Chen YL, Liao HJ, Chyuan IT, Hsu PN. Galectin-3 suppresses mucosal inflammation and reduces disease severity in experimental colitis. J Mol Med (Berl). 2016 ;94(5):545-56
10. Hsiu-Jung Liao, I-Tsu Chyuan, Chien-Sheng Wu, Shu-Wha Lin, Kun-Hung Chen, Hwei-Fang Tsai, Ping-Ning Hsu. Increased neutrophil infiltration, IL-1 production, and a SAPHO syndrome-like phenotype in PSTPIP2-deficient mice. Rheumatology 54(7):1317-26. 2015
96